Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Researchers discover breakthrough in ovarian cancer

15.02.2013
Findings from University of Arizona Cancer Center at St. Joseph's

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.

"This is a potentially important breakthrough for the Gynecologic Oncology Group," said John Farley, MD, a gynecologic oncologist in the Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology at the Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, a Dignity Health Member.

The Gynecologic Oncology Group is a non-profit international organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies.

Dr. Farley is part of the University of Arizona Cancer Center at St. Joseph's and is board certified in obstetrics and gynecology with a subspecialty certification in gynecologic oncology. He is a retired decorated Army colonel who completed a residency in obstetrics and gynecology and a fellowship in gynecologic oncology at Walter Reed Army Medical Center. He is the first author on this study.

This study was initially developed in 2007, with 52 patients enrolled for the Phase II clinical trial between December 2007 and November 2009. Patients were given 50 milligrams of selumetinib orally twice daily. Of those participants, eight had a measurable decrease in tumor size, seven had partial responses and 34 patients saw their tumors stabilize. The findings suggest that inhibitors of the MAPK pathway warrant further investigation in patients with low-grade ovarian cancer.

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us," Dr. Farley said. He added that Phase III of this trial is scheduled to begin in the next few weeks, with that trial to be the "definitive test" before the treatment becomes available to the general population.

This study is registered with ClinicalTrials.gov, number NCT00551070.

About The University of Arizona Cancer Center

The University of Arizona Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center headquartered in Arizona. The UACC is supported by NCI Cancer Center Support Grant number CA023074. With primary locations at the University of Arizona in Tucson and at St. Joseph's Hospital and Medical Center in Phoenix, the Cancer Center has more than a dozen research and education offices in Phoenix and throughout the state and 300 physician and scientist members work together to prevent and cure cancer. For more information, go to http://www.arizonacancercenter.org

About St. Joseph's Hospital and Medical Center

Located in the heart of Phoenix, Ariz., St. Joseph's Hospital and Medical Center is a 607-bed, not-for-profit hospital that provides a wide range of health, social and support services with special advocacy for the poor and underserved. St. Joseph's is a nationally recognized center for quality tertiary care, medical education and research. It includes the internationally renowned Barrow Neurological Institute, the Heart & Lung Institute, the Muhammad Ali Parkinson Center, and a Level I Trauma Center verified by the American College of Surgeons. U.S. News & World Report routinely ranks St. Joseph's among the best hospitals in the United States for neurology and neurosurgery.

Lynne Reaves | EurekAlert!
Further information:
http://www.arizonacancercenter.org
http://www.stjosephs-phx.org/index.htm

More articles from Health and Medicine:

nachricht Real-time imaging of lung lesions during surgery helps localize tumors and improve precision
30.07.2015 | American Association for Thoracic Surgery

nachricht Experimental MERS vaccine shows promise in animal studies
29.07.2015 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Gefangen in Ruhelosigkeit

Mit ultrakalten Atomen lässt sich ein neuer Materiezustand beobachten, in dem das System nicht ins thermische Gleichgewicht kommt.

Was passiert, wenn man kaltes und heißes Wasser mischt? Nach einer Weile ist das Wasser lauwarm – das System hat ein neues thermisches Gleichgewicht erreicht....

Im Focus: Quantum Matter Stuck in Unrest

Using ultracold atoms trapped in light crystals, scientists from the MPQ, LMU, and the Weizmann Institute observe a novel state of matter that never thermalizes.

What happens if one mixes cold and hot water? After some initial dynamics, one is left with lukewarm water—the system has thermalized to a new thermal...

Im Focus: Superschneller Wellenritt im Kristall: Elektronik auf Zeitskala einzelner Lichtschwingungen möglich

Physikern der Universitäten Regensburg und Marburg ist es gelungen, die von einem starken Lichtfeld getriebene Bewegung von Elektronen in einem Halbleiter in extremer Zeitlupe zu beobachten. Dabei konnten sie ein grundlegend neues Quantenphänomen entschlüsseln. Die Ergebnisse der Wissenschaftler sind jetzt in der renommierten Fachzeitschrift „Nature“ veröffentlicht worden (DOI: 10.1038/nature14652).

Die rasante Entwicklung in der Elektronik mit Taktraten bis in den Gigahertz-Bereich hat unser Alltagsleben revolutioniert. Sie stellt jedoch auch Forscher...

Im Focus: On the crest of the wave: Electronics on a time scale shorter than a cycle of light

Physicists from Regensburg and Marburg, Germany have succeeded in taking a slow-motion movie of speeding electrons in a solid driven by a strong light wave. In the process, they have unraveled a novel quantum phenomenon, which will be reported in the forthcoming edition of Nature.

The advent of ever faster electronics featuring clock rates up to the multiple-gigahertz range has revolutionized our day-to-day life. Researchers and...

Im Focus: Erster Nachweis von Lithium in einem explodierenden Stern

Erstmals konnte das chemische Element Lithium in der ausgestoßenen Materie einer Nova nachgewiesen werden. Beobachtungen von Nova Centauri 2013 mit Teleskopen des La Silla-Observatoriums der ESO und in der Nähe von Santiago de Chile helfen bei der Aufklärung des Rätsels, warum so viele junge Sterne mehr von diesem Element enthalten als erwartet. Diese Entdeckung liefert ein seit langem fehlendes Teil im Puzzle der chemischen Entwicklungsgeschichte unserer Galaxie und ist ein großer Fortschritt für das Verständnis des Mischungsverhältnisses der chemischen Elemente in den Sternen unserer Milchstraße.

Das leichte chemische Element Lithium ist eines der wenigen Elemente, das nach unserer Modellvorstellung auch beim Urknall vor 13,8 Milliarden Jahren...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Türme und Maste aus Stahl – Neues aus Forschung und Anwendung

31.07.2015 | Veranstaltungen

Tagung „Brandschutz im Tank- und Gefahrgutlager“ am 16. November 2015 im Essener Haus der Technik stellt praktische Lösungen vor

30.07.2015 | Veranstaltungen

12. BMBF-Forum für Nachhaltigkeit: Green Economy, Energiewende und die Zukunft der Städte

30.07.2015 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Wiederaufladbare Batterien machen sich breit

31.07.2015 | Seminare Workshops

Alles zur Kryotechnik: HDT bietet Seminar zum „Kryostatbau“ an

31.07.2015 | Seminare Workshops

Erster Zug von Siemens für Thameslink‑Strecke in UK angekommen

31.07.2015 | Verkehr Logistik